Latest Regulatory Risk News

Australian Clinical Labs reported a 6.4% revenue increase and an 8.7% rise in underlying EBIT for FY25, maintaining disciplined growth and operational efficiency in a complex healthcare environment.

Regis Healthcare delivered a robust FY25 performance with a 14.5% revenue increase and a dramatic turnaround to a $49 million net profit. The company is advancing growth through acquisitions and greenfield developments, positioning itself strongly ahead of upcoming sector reforms.

Liberty Group reported a solid 15.7% rise in net profit after tax to $133.3 million for FY25, supported by steady revenue growth and improved asset quality. The company also announced a special dividend, reflecting confidence in its financial position.

Carbonxt Group Limited has announced a fully underwritten non-renounceable entitlement offer of Loyalty Options to eligible shareholders, aiming to raise approximately $697,772 to support its new Activated Carbon manufacturing facility in Kentucky. The offer provides shareholders with one Loyalty Option for every six shares held, exercisable at $0.07 within three years.

Dart Mining NL’s DTMOC securities have been suspended from trading by the ASX due to non-compliance with key listing rules, raising questions about the company’s regulatory standing.

Resolute Mining reported a strong H1 2025 with revenue up 31% driven by soaring gold prices, even as production dipped due to operational challenges. The company advances key projects and maintains full-year guidance amid strategic acquisitions.

Resolute Mining Limited reported a robust half-year performance for H1 2025, with net profit more than doubling amid higher gold prices, even as production dipped due to operational challenges. The company also expanded its footprint with a strategic acquisition in Côte d’Ivoire.

Zip Co has delivered a standout FY25 with cash earnings soaring 147%, driven by rapid US market expansion. The company is now considering a Nasdaq dual listing to fuel further growth.

Zip Co Limited reported a robust FY25 with revenue up 23.5% to $1.07 billion and cash earnings soaring 147%, driven by strong US market expansion and operational efficiencies.

Latitude Group Holdings reported a robust half-year to June 2025, with revenue climbing 13.3% and statutory profit soaring 341%, while navigating ongoing regulatory investigations related to a 2023 cyber incident.

Sonic Healthcare reported solid FY2025 results with revenue up 7.6% and a steady profit increase, while declaring a 63-cent final dividend. The company’s recent German acquisition and ongoing synergy efforts set the stage for robust earnings growth in FY2026.

Telix Pharmaceuticals reported a robust 63% year-over-year revenue increase in H1 2025, driven by strong sales of its precision medicine products and strategic acquisitions. The company is advancing multiple late-stage clinical trials and expanding its global manufacturing footprint.